Jafar Mohseni

Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function

Sanaz Abbaspour‐Aghdam, Ali Hazrati, Samaneh Abdolmohammadi‐Vahid et al. · European Journal of Pharmacology · 2022 · 18 citations · Full text

Nanomedicine, Viral Immunity, Immunology +11

Two Novel Gross Deletions of TSC2 in Malaysian Patients with Tuberous Sclerosis Complex and TSC2/PKD1 Contiguous Deletion Syndrome

Nur Farrah Dila Ismail, Nik Mohd Ariff Nik Abdul Malik, Jafar Mohseni et al. · Japanese Journal of Clinical Oncology · 2014 · 15 citations · Full text

Malaysian Patients, Genetics, Immunology +18

Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients

Jafar Mohseni, Belal O. Al‐Najjar, Habibah A. Wahab et al. · Journal of Human Genetics · 2016 · 13 citations

Hdac Inhibitors, Smn2 Expression, Oncogenic Agent +9

Novel complex Re-Arrangement of ARG1 commonly shared by unrelated patients with Hyperargininemia

Jafar Mohseni, Chia Boon Hock, Che Abdul Razak et al. · Gene · 2013 · 12 citations

Unrelated Patients, Novel Complex Re-arrangement, Autoimmune Disease +4